Physician Assistant · Virginia Beach, VA
NPI
1235178302
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1950 Glenn Mitchell Dr Ste 200
Virginia Beach, VA, 23456
Phone (757) 507-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
482 services
Medicare patients, 2024
225
Average age 73
Drug cost, 2024
$844K
1,858 prescriptions
Company payments, 2025
$13K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica M Cain was code 99214 (office e&m - established), 198 times for 175 patients. In total Jessica M Cain billed 482 services in 17 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 198 | 175 | $64.40 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 108 | $10.31 | $1,206 |
| 99215 Office E&M - Established | Office | 35 | 33 | $112.77 | $3,947 |
| 99213 Office E&M - Established | Office | 20 | 19 | $31.57 | $631 |
By year: 2023 $18K for 222 services; 2024 $20K for 482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica M Cain prescribed most often to Medicare patients was Gabapentin, with 149 prescriptions and refills. In total Jessica M Cain wrote 1,858 Medicare prescriptions that cost $844K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 149 | 246 | 57 | $2,971 |
| Memantine Hcl Generic | 136 | 216 | 53 | $3,226 |
| Levetiracetam Generic | 109 | 193 | 33 | $3,624 |
| Donepezil Hcl Generic | 96 | 210 | 39 | $1,070 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 79 | 158 | 34 | $2,452 |
| Topiramate Generic | 48 | 86 | 16 | $480 |
| Quetiapine Fumarate Generic | 42 | 66 | 16 | $536 |
| Levetiracetam Er Levetiracetam | 39 | 87 | 13 | $4,446 |
| Baclofen Generic | 38 | 62 | 14 | $510 |
| Duloxetine Hcl Generic | 37 | 60 | Under 11 | $589 |
| Tramadol Hcl Generic | 36 | 36 | Under 11 | $650 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 36 | 36 | Under 11 | $282K |
| Aimovig Autoinjector Erenumab-Aooe | 36 | 51 | 11 | $37K |
| Cyclobenzaprine Hcl Generic | 32 | 55 | 15 | $328 |
| Lamotrigine Generic | 30 | 71 | 11 | $900 |
Brand drugs: - claims; generic drugs: 1,611 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica M Cain $13K ($13K in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $5,284.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $5,284 |
| Axsome Therapeutics, Inc. AXSM | 12 | $5,203 |
| Merz Pharmaceuticals, LLC | 5 | $639 |
| TG Therapeutics, Inc. TGTX | 12 | $348 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $187 |
| Amgen Inc. AMGN | 9 | $176 |
| UCB, Inc. UCB.BR | 8 | $169 |
| Celgene Corporation BMY | 15 | $150 |
| Biogen, Inc. BIIB | 8 | $144 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.